申请人:Bristol-Myers Squibb Company
公开号:US07601836B2
公开(公告)日:2009-10-13
Pyrido[2,3-d]pyrimidine phosphodiesterase 7 (PDE 7) inhibitors are provided which are useful in treating T-cell mediated diseases, said inhibitors include:
(i) 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; and
4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; or
(ii) an enantiomer, diastereomer, tautomer or pharmaceutically acceptable salt of (i).
提供了用于治疗T细胞介导疾病的Pyrido [2,3-d] pyrimidine磷酸二酯酶7(PDE 7)抑制剂,该抑制剂包括:(i)2- [[4- [[[4-(氨基磺酰)苯基] 甲基] 氨基] ] pyrido [2,3-d] pyrimidin-2-yl]氨基] -4-甲基-5-噻唑羧酸,乙酯; 和4-甲基-2-[[4-[[[4-(甲基磺酰)苯基]甲基]氨基]pyrido[2,3-d]pyrimidin-2-yl]氨基]-5-噻唑羧酸,乙酯; 或(ii)(i)的对映体,非对映体异构体,互变异构体或药学上可接受的盐。